Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03440229 · ClinicalTrials.gov registry record · NA

Functional Research of Emulsifiers in Humans

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT03440229: Completed NA study, sponsored by University of Pennsylvania.

NCT03440229 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03440229, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

A randomized double-blind study of the effect of carboxymethylcellulose (CMC) on stool microbiota composition, microbiota localization, and metabolic parameters in healthy subjects. It includes a 11-day in-patient stay, randomization to an emulsifier-free group or a CMC group with the same diet except baked goods/sorbet with added CMC at 15g/person/day.

Primary Outcome

Measured distance from the epithelium to the nearest bacteria under high powered microscopy; The measurements were taken on the last day of the diet intervention. An average of 3 measurements was taken.

Interventions

  • OTHER Emulsifier-containing diet

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2018-04-06
Est. Completion 2019-05-13
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT03440229 record still lists

NCT03440229 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Emulsifier-containing diet is the first listed.

NCT03440229 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03440229 about?

NCT03440229 is a clinical study titled "Functional Research of Emulsifiers in Humans". A randomized double-blind study of the effect of carboxymethylcellulose (CMC) on stool microbiota composition, microbiota localization, and metabolic parameters in healthy subjects. It includes a 11-day in-patient stay, randomization to an emulsifier-free group or a CMC group with the same diet exce...

What is the current status of trial NCT03440229?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-04-06. Estimated completion is 2019-05-13.

What interventions are being tested in trial NCT03440229?

The interventions under investigation include: Emulsifier-containing diet (OTHER).

Who is sponsoring clinical trial NCT03440229?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03440229's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03440229, the US trial registry maintained by the National Library of Medicine. NCT03440229 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.